{"title":"成人支气管扩张患者住院费用的影响因素分析","authors":"Y. Lei, Lineng Zhou, Yanli Yang, Tinglong Li","doi":"10.11648/J.AJNS.20211001.26","DOIUrl":null,"url":null,"abstract":"Objective: To explore Influencing factors of hospitalization costs in adult patients with bronchiectasis. Methods: The data were collected from public hospitals in China between May 2016 and December 2019, the information collected includes the following: total hospitalization cost, age, sex, blood routine, length of stay, and complications. Result: A total of 462 effective cases were collected in this study, including 234 males (50.65%) and 228 females (49.35%). In hospitalization costs, single total hospitalization cost is 13610.87 yuan per capita, among them the quartile is 7453.50 yuan, the median is 9893.51 yuan, upper quartile is 14153.62 yuan. Base on the proportion of hospitalization costs in adult patients with bronchiectasis, the drug cost was the highest (40.53%), the test cost was the second (20.59), and the nursing cost was the lowest (2.59%). In results of univariate analysis of cases with different characteristics, chronic obstructive pulmonary disease (COPD), smoking history, age, duration of hospitalization, and the percentage of neutrophils were statistical significance (p < 0.05). independent factors. Conclusion: independent factors of hospitalization costs in adult patients with bronchiectasis included hospitalization duration, smoking history, COPD, and high neutrophil percentage. Therefore, medical staffs should control and avoid those factors in treatment of adult patients with bronchiectasis.","PeriodicalId":344042,"journal":{"name":"American Journal of Nursing Science","volume":"6 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Influencing Factors of Hospitalization Costs in Adult Patients with Bronchiectasis\",\"authors\":\"Y. Lei, Lineng Zhou, Yanli Yang, Tinglong Li\",\"doi\":\"10.11648/J.AJNS.20211001.26\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective: To explore Influencing factors of hospitalization costs in adult patients with bronchiectasis. Methods: The data were collected from public hospitals in China between May 2016 and December 2019, the information collected includes the following: total hospitalization cost, age, sex, blood routine, length of stay, and complications. Result: A total of 462 effective cases were collected in this study, including 234 males (50.65%) and 228 females (49.35%). In hospitalization costs, single total hospitalization cost is 13610.87 yuan per capita, among them the quartile is 7453.50 yuan, the median is 9893.51 yuan, upper quartile is 14153.62 yuan. Base on the proportion of hospitalization costs in adult patients with bronchiectasis, the drug cost was the highest (40.53%), the test cost was the second (20.59), and the nursing cost was the lowest (2.59%). In results of univariate analysis of cases with different characteristics, chronic obstructive pulmonary disease (COPD), smoking history, age, duration of hospitalization, and the percentage of neutrophils were statistical significance (p < 0.05). independent factors. Conclusion: independent factors of hospitalization costs in adult patients with bronchiectasis included hospitalization duration, smoking history, COPD, and high neutrophil percentage. Therefore, medical staffs should control and avoid those factors in treatment of adult patients with bronchiectasis.\",\"PeriodicalId\":344042,\"journal\":{\"name\":\"American Journal of Nursing Science\",\"volume\":\"6 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-04-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of Nursing Science\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.11648/J.AJNS.20211001.26\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Nursing Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.11648/J.AJNS.20211001.26","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Influencing Factors of Hospitalization Costs in Adult Patients with Bronchiectasis
Objective: To explore Influencing factors of hospitalization costs in adult patients with bronchiectasis. Methods: The data were collected from public hospitals in China between May 2016 and December 2019, the information collected includes the following: total hospitalization cost, age, sex, blood routine, length of stay, and complications. Result: A total of 462 effective cases were collected in this study, including 234 males (50.65%) and 228 females (49.35%). In hospitalization costs, single total hospitalization cost is 13610.87 yuan per capita, among them the quartile is 7453.50 yuan, the median is 9893.51 yuan, upper quartile is 14153.62 yuan. Base on the proportion of hospitalization costs in adult patients with bronchiectasis, the drug cost was the highest (40.53%), the test cost was the second (20.59), and the nursing cost was the lowest (2.59%). In results of univariate analysis of cases with different characteristics, chronic obstructive pulmonary disease (COPD), smoking history, age, duration of hospitalization, and the percentage of neutrophils were statistical significance (p < 0.05). independent factors. Conclusion: independent factors of hospitalization costs in adult patients with bronchiectasis included hospitalization duration, smoking history, COPD, and high neutrophil percentage. Therefore, medical staffs should control and avoid those factors in treatment of adult patients with bronchiectasis.